Shares of Danaher Corp. DHR advanced 1.43% to $238.20 Monday, on what proved to be an all-around mixed trading session for ...

Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on ...

A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The ...

Immunoassay analyzers are used to identify and detect the concentration of specific substances in a sample, usually using an antibody as a reagent. These devices are used in hospitals and clinical ...

A line-up of experts across academia, pharma, and healthcare came together to discuss the impact and challenges of ...

Discover why Danaher is a strong investment choice with its wide moat business model, M&A strategy, and growth potential for ...